Drug company payments to doctors still hard to access despite disclosure lawsBMJ 2007; 334 doi: http://dx.doi.org/10.1136/bmj.39164.663044.DB (Published 29 March 2007) Cite this as: BMJ 2007;334:655
- Fred Charatan
An attempt to use disclosure laws passed by two US states to discover the sums of money paid by drug companies to doctors found the relevant information was of limited quality and hard to access.
The US states of California, Maine, West Virginia, Vermont, Minnesota, and the District of Columbia have laws mandating disclosure of payments made to doctors by drug companies. In two of these states, Vermont and Minnesota, payment disclosures are meant to be publicly available.
The Vermont law, enacted in 2001, requires drug companies to disclose any gift or payment of $25 (£13; €19) or more to doctors, hospitals, nursing …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial